Cases 1 - 10 of 157
CELGENE CORPORATION v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al
as 2:2024cv00500
Plaintiff:
CELGENE CORPORATION
Defendant:
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL EU, LIMITED and AMNEAL PHARMACEUTICALS LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. ACCORD HEALTHCARE, INC.
as 2:2023cv21189
Plaintiff:
CELGENE CORPORATION
Defendant:
ACCORD HEALTHCARE, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. MSN Laboratories Private Limited et al
as 1:2023cv00699
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. DEVA HOLDING A.S.
as 2:2023cv02992
Plaintiff:
CELGENE CORPORATION
Defendant:
DEVA HOLDING A.S.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Accord Healthcare Inc.
as 1:2023cv00424
Plaintiff:
Celgene Corporation, Celgene International Srl, Bristol-Myers Squibb Company and others
Defendant:
Accord Healthcare Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. QILU PHARMACEUTICAL CO. LTD.
as 2:2022cv03753
Plaintiff:
CELGENE CORPORATION
Defendant:
QILU PHARMACEUTICAL CO. LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. ONCOGEN PHARMA (MALAYSIA) SDN. BHD.
as 2:2022cv02952
Plaintiff:
CELGENE CORPORATION
Defendant:
ONCOGEN PHARMA (MALAYSIA) SDN. BHD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. MSN LABORATORIES PRIVATE LIMITED et al
as 2:2022cv01993
Plaintiff:
CELGENE CORPORATION
Defendant:
MSN LABORATORIES PRIVATE LIMITED and MSN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
